AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 282: H219-H231, 2002;
0363-6135/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (23)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Piech, A.
Right arrow Articles by Balligand, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Piech, A.
Right arrow Articles by Balligand, J.-L.
Vol. 282, Issue 1, H219-H231, January 2002

Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy

A. Piech1,*, P. E. Massart2,*, C. Dessy1, O. Feron1, X. Havaux2, N. Morel3, J.-L. Vanoverschelde2, J. Donckier4, and J.-L. Balligand1

1 Unit of Pharmacology and Therapeutics, 2 Division of Cardiology, and Departments of 3 Physiology and 4 Internal Medicine, Université Catholique de Louvain, B-1200 Brussels, Belgium

Because nitric oxide (NO) regulates cardiac and vessel contraction, we compared the expression and activity of the endothelial NO synthase (eNOS) and caveolin, which tonically inhibits eNOS in normal and hypertrophic cardiomyopathic hearts. NOS activity (L-[3H]citrulline formation), eNOS immunostaining, and caveolin abundance were measured in heart tissue of 23 mongrel dogs before and at 3 and 7 wk of perinephritic hypertension (PHT). Hemodynamic parameters in vivo and endothelial NO-dependent relaxation of macro- and coronary microvessels in vitro were assessed in the same animals. eNOS immunostaining and total calcium-dependent NOS activity decreased at 7 wk in all four heart cavities (in left ventricle, from 17.0 ± 1.3 to 0.2 ± 0.2 fmol · min-1 · mg protein-1, P < 0.001). Caveolin-1 and -3 also decreased in PHT dog hearts. Accordingly, basal vascular tone was preserved, but maximal endothelial NO-dependent relaxation was impaired in all vessels from 7-wk PHT dogs. The latter had preserved systolic function but impaired diastolic relaxation [relaxation time constant (T1), 25.1 ± 0.9 vs. 22.0 ± 1 ms in controls; P < 0.05]. Peripheral infusion of the NOS inhibitor NG-nitro-L-arginine methyl ester increased mean aortic pressure in both groups and reduced diastolic (T1, 31.9 ± 1.4 ms) and systolic function in PHT dogs (DP40, 47.5 ± 2.5 vs. 59.4 ± 3.8 s-1 in control animals). In conclusion, both eNOS and caveolin proteins are decreased in the hypertrophic hearts of PHT dogs. This is associated with altered maximal (but not basal) vascular relaxation and impaired diastolic function. Further degradation of cardiac function after NOS inhibition suggests a critical role of residual NOS activity, probably supported by the concurrent downregulation of caveolin.

cardiac hypertrophy; diastolic function; perinephritic hypertension; endothelial nitric oxide synthase

* These authors contributed equally to this work.




This article has been cited by other articles:


Home page
 HypertensionHome page
G. Ruiz-Hurtado, M. Fernandez-Velasco, M. Mourelle, and C. Delgado
LA419, a Novel Nitric Oxide Donor, Prevents Pathological Cardiac Remodeling in Pressure-Overloaded Rats Via Endothelial Nitric Oxide Synthase Pathway Regulation
Hypertension, December 1, 2007; 50(6): 1049 - 1056.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
B. J. Holycross, M. Kukielka, Y. Nishijima, R. A. Altschuld, C. A. Carnes, and G. E. Billman
Exercise training normalizes beta-adrenoceptor expression in dogs susceptible to ventricular fibrillation
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2702 - H2709.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
S. Wenzel, C. Rohde, S. Wingerning, J. Roth, G. Kojda, and K.-D. Schluter
Lack of Endothelial Nitric Oxide Synthase-Derived Nitric Oxide Formation Favors Hypertrophy in Adult Ventricular Cardiomyocytes
Hypertension, January 1, 2007; 49(1): 193 - 200.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J.-F. Jasmin, I. Mercier, J. Dupuis, H. B. Tanowitz, and M. P. Lisanti
Short-Term Administration of a Cell-Permeable Caveolin-1 Peptide Prevents the Development of Monocrotaline-Induced Pulmonary Hypertension and Right Ventricular Hypertrophy
Circulation, August 29, 2006; 114(9): 912 - 920.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
W.-W. Lin, Y.-C. Lin, T.-Y. Chang, S.-H. Tsai, H.-C. Ho, Y.-T. Chen, and V. C. Yang
Caveolin-1 Expression Is Associated with Plaque Formation in Hypercholesterolemic Rabbits
J. Histochem. Cytochem., August 1, 2006; 54(8): 897 - 904.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
C. Ballard-Croft, A. C. Locklar, G. Kristo, and R. D. Lasley
Regional myocardial ischemia-induced activation of MAPKs is associated with subcellular redistribution of caveolin and cholesterol
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H658 - H667.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
O. Feron and J.-L. Balligand
Caveolins and the regulation of endothelial nitric oxide synthase in the heart
Cardiovasc Res, March 1, 2006; 69(4): 788 - 797.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J.-L. Balligand
"La Donna e Mobile...": Is Cardiac Neuronal Nitric Oxide Synthase Such a Disconcerting Enzyme?
Circulation, December 13, 2005; 112(24): 3668 - 3671.
[Full Text] [PDF]

Home page
 Cardiovasc ResHome page
J.-F. Jasmin, I. Mercier, R. Hnasko, M. W.-C Cheung, H. B Tanowitz, J. Dupuis, and M. P Lisanti
Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression
Cardiovasc Res, September 1, 2004; 63(4): 747 - 755.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
P. Sonveaux, P. Martinive, J. DeWever, Z. Batova, G. Daneau, M. Pelat, P. Ghisdal, V. Gregoire, C. Dessy, J.-L. Balligand, et al.
Caveolin-1 Expression Is Critical for Vascular Endothelial Growth Factor-Induced Ischemic Hindlimb Collateralization and Nitric Oxide-Mediated Angiogenesis
Circ. Res., July 23, 2004; 95(2): 154 - 161.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
B. Aravamudan, D. Volonte, R. Ramani, E. Gursoy, M. P. Lisanti, B. London, and F. Galbiati
Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype
Hum. Mol. Genet., November 1, 2003; 12(21): 2777 - 2788.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
A. W. Cohen, D. S. Park, S. E. Woodman, T. M. Williams, M. Chandra, J. Shirani, A. Pereira de Souza, R. N. Kitsis, R. G. Russell, L. M. Weiss, et al.
Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts
Am J Physiol Cell Physiol, February 1, 2003; 284(2): C457 - C474.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
P. Ratajczak, T. Damy, C. Heymes, P. Oliviero, F. Marotte, E. Robidel, R. Sercombe, J. Boczkowski, L. Rappaport, and J.-L. Samuel
Caveolin-1 and -3 dissociations from caveolae to cytosol in the heart during aging and after myocardial infarction in rat
Cardiovasc Res, February 1, 2003; 57(2): 358 - 369.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
A. Piech, C. Dessy, X. Havaux, O. Feron, and J.-L. Balligand
Differential regulation of nitric oxide synthases and their allosteric regulators in heart and vessels of hypertensive rats
Cardiovasc Res, February 1, 2003; 57(2): 456 - 467.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D. S. Park, S. E. Woodman, W. Schubert, A. W. Cohen, P. G. Frank, M. Chandra, J. Shirani, B. Razani, B. Tang, L. A. Jelicks, et al.
Caveolin-1/3 Double-Knockout Mice Are Viable, but Lack Both Muscle and Non-Muscle Caveolae, and Develop a Severe Cardiomyopathic Phenotype
Am. J. Pathol., June 1, 2002; 160(6): 2207 - 2217.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online